218 related articles for article (PubMed ID: 11801674)
21. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H
Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253
[TBL] [Abstract][Full Text] [Related]
22. Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated to TCR avidity.
Yang S; Linette GP; Longerich S; Haluska FG
J Immunol; 2002 Jul; 169(1):531-9. PubMed ID: 12077285
[TBL] [Abstract][Full Text] [Related]
23. Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer.
Albers AE; Qian X; Kaufmann AM; Mytilineos D; Ferris RL; Hoffmann TK; DeLeo AB
Sci Rep; 2018 Jul; 8(1):10716. PubMed ID: 30013227
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.
Yang S; Kittlesen D; Slingluff CL; Vervaert CE; Seigler HF; Darrow TL
J Immunol; 2000 Apr; 164(8):4204-11. PubMed ID: 10754316
[TBL] [Abstract][Full Text] [Related]
25. MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL.
Gagnon SJ; Wang Z; Turner R; Damirjian M; Biddison WE
J Immunol; 2003 Sep; 171(5):2233-41. PubMed ID: 12928367
[TBL] [Abstract][Full Text] [Related]
26. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope.
Theobald M; Ruppert T; Kuckelkorn U; Hernandez J; Häussler A; Ferreira EA; Liewer U; Biggs J; Levine AJ; Huber C; Koszinowski UH; Kloetzel PM; Sherman LA
J Exp Med; 1998 Sep; 188(6):1017-28. PubMed ID: 9743520
[TBL] [Abstract][Full Text] [Related]
27. The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire.
Hernández J; Lee PP; Davis MM; Sherman LA
J Immunol; 2000 Jan; 164(2):596-602. PubMed ID: 10623800
[TBL] [Abstract][Full Text] [Related]
28. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.
Hong J; Zang YC; Tejada-Simon MV; Kozovska M; Li S; Singh RA; Yang D; Rivera VM; Killian JK; Zhang JZ
J Immunol; 1999 Sep; 163(6):3530-8. PubMed ID: 10477628
[TBL] [Abstract][Full Text] [Related]
29. Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs.
Uemura Y; Senju S; Maenaka K; Iwai LK; Fujii S; Tabata H; Tsukamoto H; Hirata S; Chen YZ; Nishimura Y
J Immunol; 2003 Jan; 170(2):947-60. PubMed ID: 12517961
[TBL] [Abstract][Full Text] [Related]
30. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
31. Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus.
Prod'homme V; Retière C; Imbert-Marcille BM; Bonneville M; Hallet MM
J Immunol; 2003 Feb; 170(4):2030-6. PubMed ID: 12574373
[TBL] [Abstract][Full Text] [Related]
32. T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.
Butterfield LH; Meng WS; Koh A; Vollmer CM; Ribas A; Dissette VB; Faull K; Glaspy JA; McBride WH; Economou JS
J Immunol; 2001 Apr; 166(8):5300-8. PubMed ID: 11290817
[TBL] [Abstract][Full Text] [Related]
33. Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B*4601-restricted and tumor cell-reactive CTLs at tumor site.
Azuma K; Shichijo S; Maeda Y; Nakatsura T; Nonaka Y; Fujii T; Koike K; Itoh K
Cancer Res; 2003 Feb; 63(4):854-8. PubMed ID: 12591737
[TBL] [Abstract][Full Text] [Related]
34. Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8+ cytotoxic lymphocyte population.
Kalergis AM; Ono T; Wang F; DiLorenzo TP; Honda S; Nathenson SG
J Immunol; 1999 Jun; 162(12):7263-70. PubMed ID: 10358174
[TBL] [Abstract][Full Text] [Related]
35. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
[TBL] [Abstract][Full Text] [Related]
36. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
Bristol JA; Schlom J; Abrams SI
J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
[TBL] [Abstract][Full Text] [Related]
37. Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma.
Cicinnati VR; Zhang X; Yu Z; Ferencik S; Schmitz KJ; Dworacki G; Kaczmarek E; Oldhafer K; Frilling A; Baba HA; Schmid KW; Grosse-Wilde H; Broelsch CE; DeLeo AB; Gerken G; Beckebaum S
Int J Cancer; 2006 Dec; 119(12):2851-60. PubMed ID: 16998881
[TBL] [Abstract][Full Text] [Related]
38. HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
Chauvin JM; Larrieu P; Sarrabayrouse G; Prévost-Blondel A; Lengagne R; Desfrançois J; Labarrière N; Jotereau F
J Immunol; 2012 Mar; 188(5):2102-10. PubMed ID: 22291187
[TBL] [Abstract][Full Text] [Related]
39. Characterization of CD8+ cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant.
Hilburger Ryan M; Abrams SI
Cancer Immunol Immunother; 2001 Jan; 49(11):603-12. PubMed ID: 11225991
[TBL] [Abstract][Full Text] [Related]
40. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]